Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of DigitalGlassware Online Portal

12 Aug 2019 07:00

RNS Number : 6231I
DeepMatter Group PLC
12 August 2019
 

 

Launch of DigitalGlassware™ Online Portal

First look at the uniquely rich, contextualised experiment data recorded by DigitalGlassware™, aiming to solve the reproducibility problem in chemistry

 

12 August 2019 - DeepMatter, the AIM-listed company at the forefront of digitizing chemistry, today announces the launch of its open access DigitalGlasswareTM online portal, which allows the scientific world to view and interact with the shareable data originated from chemistry lab experiments conducted using DeepMatter's proprietary technology.

 

The online portal allows individuals to visualise and interact with the uniquely contextualised, rich and real-time data that DeepMatter's innovative cloud-based platform (DigitalGlassware™) generates recording experiments. This includes data points such as temperature, UV light levels, pressure and more.

 

To demonstrate the capabilities of the technology, the DigitalGlasswareTM online platform has today been populated with the data from an example experiment: a selective amination of an alcohol under mild conditions.

 

Going forward, the portal will be regularly updated with the outcomes of other experiments, showing how DigitalGlassware™ works under real reaction scenarios and, crucially, how it can save time and money and increase lab productivity. These will be supported by blog post 'data stories', providing guidance to help users familiarise themselves with DigitalGlassware™.

 

The online portal can be found at https://public.deepmatter.tech;

and the associated blog post at: https://www.deepmatter.io/blog

 

This one example is a demonstration of the depth of data that will ultimately be openly accessible across an increasing library of experiments through the DigitalGlasswareTM digital platform.

 

This level of data sharing will allow scientists to re-create experiments to a greater degree of accuracy. Ultimately, the aim is to solve the billion-dollar reproducibility problem.

 

The portal will be consistently developed and refined, with chemists eventually able to upload their own 'recipes' and run data through the portal.

 

Mark Warne, CEO of DeepMatter, commented:

 

"This is a fantastic opportunity to demonstrate our DigitalGlassware™ platform to a broader audience of chemists. Our aim is for our software to become truly integral to research and process chemistry, providing those involved with a cost-effective, easy-to-use solution that will save significant time, effort and money. The launch of this platform is a significant step towards achieving the sharing and recording of detailed data in real time across the chemistry industry, making reproducibility much more achievable."

 

About DeepMatter

 

DeepMatter Group Plc is a big data and analysis company which has built a technology platform - DigitalGlassware™, focused on enabling reproducibility in chemistry. It continues to develop this software to deliver applications resulting in new optimised chemicals, materials and formulations in such commercially significant areas as pharmaceutical research, fine chemicals, scientific publications and teaching. DeepMatter is at the forefront of the digitization of chemistry, which will ultimately see the enabling of an autonomous synthesis engine, the Chemputer™.

 

Paying clients of the DigitalGlasswareTM platform are able to nominate which data remains proprietary, for their sole use, and which can be made shareable via the Online Portal.

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAPLMATMBJMBRL
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.